Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair
- 9 Downloads
Introduction and hypothesis
Opportunistic salpingectomy (OS) at the time of benign hysterectomy has recently emerged as a potential primary preventive modality for ovarian cancer. Our objective was to determine whether the reported rate of OS at the time of prolapse surgery is similar to the rate of OS at the time of gynecologic surgery for non-prolapse indications.
An anonymous online survey was sent to the Society of Gynecologic Surgery members. Responses were divided into surgeons who did and did not perform OS at the time of prolapse repair. Differences between surgeons who did and did not perform OS were evaluated using the chi-square test. Multivariable logistic regression was used to identify which responses related to increased odds of performing OS.
There were 117 (33.1%) completed responses; of these, 98 (83.8%) reported performing OS at the time of prolapse repair, which was similar to the reported rate of OS at the time of hysterectomy for non-prolapse indications, 82.1%. After multivariable logistic regression, performance of salpingectomy at the time of hysterectomy for a non-prolapse indication (aOR: 17.9, 95% CI: 3.11–42.01), use of a laparoscopic or robotic surgical approach (aOR 14.1, 95% CI: 1.81–32.21) and completion of an FPMRS fellowship (aOR: 3.47, 95% CI: 1.20–10.02) were associated with a higher likelihood of performing OS at the time of prolapse repair.
OS at the time prolapse repair is performed more frequently with concomitant hysterectomy compared with OS at the time of post-hysterectomy prolapse repair and is similar to rates of OS performed at the time of hysterectomy for non-prolapse indications.
KeywordsOpportunistic salpingectomy Pelvic organ prolapse Ovarian cancer
Compliance with ethical standards
Conflicts of interest
- 1.United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Accessed November 25, 2017.Google Scholar
- 2.www.mskcc.org/cancer-care/types/ovarian/screening/screening-guidelines-ovarian. Accessed November 25, 2017.
- 6.Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol Oncol. 2008;110(3):408–17.CrossRefPubMedGoogle Scholar
- 22.Lamblin G, Meysonnier C, Moret S, Nadaud B, Mellier G, Chene G. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition. Int Urogynecol J. 2017;1-7.Google Scholar
- 25.Garcia C, Martin M, Tucker LY, Lyon L, Armstrong MA, McBride-Allen S, et al. Experience with opportunistic salpingectomy in a large, community-based health system in the United States. Obstet Gynecol. 2016;128(2):277–83.Google Scholar
- 28.Mohamed AA, Yosef AH, James C, Al-Hussaini TK, Bedaiwy MA, Amer SA. Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017.Google Scholar
- 30.Mikami M, Nagase S, Yamagami W, Ushijma K, Tashiro H, Katabuchi H. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of gynecologic oncology committee of japan society of obstetrics and gynecology. J Gynecol Oncol. 2017;28(4).Google Scholar